Research for health and the prevention and better treatment of common diseases are the goals of the German Centers for Health Research (DZG). At the 2nd DZG Munich Day on July 12, 2024, the eight DZG…
On Friday, June 7, this year’s Postdoc Symposium including the DKTK Young Academics Conference 2024 took place at the DKFZ Communication Center. The PDN-Committee, supported by the Postdoc Office and…
United against common diseases! This is the mission of the German Centers for Health Research (DZG). Their scientists are working to optimize the translation of research results into patient care,…
Cell-based cancer therapies often fail nowadaystoday because the immune cells are unable to penetrate the tumor efficiently. The use of certain phagocytes is considered a promising alternative - but…
Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system. In this way, the body presumably curbs…
Tumors actively prevent the formation of immune responses by so-called cytotoxic T cells, which are essential in combating cancer. Researchers at the Technical University of Munich (TUM) and the…
The European Research Council (ERC) supports visionary, ground-breaking research projects with its Advanced Grant. This year, the Council awarded the prestigious funding to the Neurologist Michael…
This year's winners of the Waltraud Lewenz Prize are a team of young scientists: Senior Postdoc Dr. Ashish Goyal (Heidelberg) together with his co-first authors PhD student Jens Bauer (Tübingen) and…
In the DKTK School of Oncology's first Tech Talk of 2024 on March 12, Dr. Christof Winter and PD Hedwig Deubzer discussed the benefits of Liquid Biopsies in pediatric and adult cancers.
150 representatives from six German Centers for Health Research (DZG) from the partner sites in Heidelberg and Mannheim met on February, 28 2024 for the first DZG Heidelberg-Mannheim Day. Overview…
The 6th Joint Dresden DZG Symposium took place on March 26, 2024: The three German Centers for Health Research (DZG) located in Dresden play a significant role on Dresden's biomedical campus, with 250…
The DZG Innovation Fund (DZGIF) is a joint research funding program of the German Centers for Health Research. For each round of calls for proposals, there will be an agreed research topic that allows…
Making a personalised T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ), the University Medical Center Mannheim and the…
After stem cell transplantation, the donated immune cells sometimes attack the patients' bodies. This is known as graft versus host disease or GvHD. Researchers at the Technical University of Munich…
New epigenetic inhibitor is also effective in treatment-resistant prostate cancer cells
The fourth DKFZ/NCT/DKTK HARPOON workshop took place in Heidelberg on November 23 and 24 with lively participation of well over 100 experts in attendance. HARPOON stands for HArmonisation of Reporting…
Leukemia is the most common type of cancer in children. Treatment involves intensive chemotherapy, which has severe side effects due to its non-specific mode of action. A team from the Department of…
Epigenetically active drugs enable the cell to read parts of the genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as…
Scientists from the German Cancer Research Center (DKFZ), the University Medical Center Mannheim (UMM) and the German Cancer Consortium (DKTK) successfully tested a new form of cellular immunotherapy…
At the already 10th Munich Cancer Retreat (MCR10), the Key Note Lectures were given by two new members of the DKTK Scientific Advisory Board (SAB). Stefanie Polat (Siemens Healthineers, Erlangen)…